Illegal Activity
none
Blackmail
none
Date
4/2/14
Document Type
other
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:43
Summary
This document is a snapshot of an investment portfolio as of April 2, 2014, detailing the performance of various biotech stocks. It includes information on trade dates, quantities, prices, market values, and unrealized gains/losses for each stock.
Metadata
- Subject
- Investment Portfolio
- Sender
- —
- Recipients
- —
- Document ID
- DB-SDNY-0101619 SDNY_GM_00247803
- Date
- 4/2/14
Financial Information
Amounts:17.518.44875,500.00422,214.00453,286.00308.71119.55646,747.45250,454.95396,292.5031.6227.51790,500.00687,663.50102,836.5073.7979.41597,699.00643,204.00(45,505.00)3,043,139.832,294,533.85906,910.008.0317.60132,693.38290,997.40(158,304.03)
Assets:
- SANGAMO BIOSCIENCES
- BIOGEN
- FOUNDATION MEDICINE
- GILEAD SCIENCES INC
- ARIAD PHARMACEUTICALS
Raw Analysis JSON
click to expand
Themes
Financial transactions/money flow
Organizations 5
SANGAMO BIOSCIENCESBIOGENFOUNDATION MEDICINEGILEAD SCIENCES INCARIAD PHARMACEUTICALS
Text Analysis
- Tone
- Informative
- Purpose
- To provide a snapshot of an investment portfolio's performance as of 4/2/14.
- Significance
- Shows the market value, cost, and unrealized gains/losses for various biotech stocks.
File Info
- File Name
- EFTA01447101.txt
- Dataset
- dataset_10
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:43:50.306464
- DOJ Source
- View on DOJ